← back to search

Jennifer C. Felger

Emory University · US
Area of research
Biological Psychiatry · Behavioral Neuroscience
Research interest
Research interests include Tryptophan and brain disorders, Stress Responses and Cortisol, Neuroinflammation and Neurodegeneration Mechanisms, and Cancer survivorship and care.
h-index
49
citations
9,556
works
158
NIH funding
primary concept
email

Recent publications

Designing Clinical Trials for an Inflammatory Subtype of Major Depressive Disorder
Biological Psychiatry 2025cited by 10position: middledoi
A randomized proof-of-mechanism trial of TNF antagonism for motivational deficits and related corticostriatal circuitry in depressed patients with high inflammation
Molecular Psychiatry 2024cited by 30position: middledoi
Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators
Neuropsychopharmacology 2023cited by 27position: middledoi
Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology
Biological Psychiatry 2022cited by 203position: lastdoi
The role of the immune system in posttraumatic stress disorder
Translational Psychiatry 2022cited by 152position: middledoi
Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study
Molecular Psychiatry 2022cited by 107position: lastdoi
Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications
Current topics in behavioral neurosciences 2022cited by 59position: lastdoi
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation
The Journal of Clinical Psychiatry 2022cited by 51position: middledoi
Inflammation, amygdala-ventromedial prefrontal functional connectivity and symptoms of anxiety and PTSD in African American women recruited from an inner-city hospital: Preliminary results
Brain Behavior and Immunity 2022cited by 27position: lastdoi
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Pharmacological Reviews 2021cited by 111position: middledoi
Influences of dopaminergic system dysfunction on late-life depression
Molecular Psychiatry 2021cited by 87position: middledoi
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study
Cancer 2021cited by 63position: middledoi
Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogramming
Molecular Psychiatry 2021cited by 28position: lastdoi
Kynurenines increase MRS metabolites in basal ganglia and decrease resting-state connectivity in frontostriatal reward circuitry in depression
Translational Psychiatry 2021cited by 24position: middledoi
Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression
Neuropsychopharmacology 2020cited by 165position: middledoi
Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia
Brain Behavior and Immunity 2020cited by 74position: lastdoi
Inflammation, reward circuitry and symptoms of anhedonia and PTSD in trauma-exposed women
Social Cognitive and Affective Neuroscience 2020cited by 67position: lastdoi
Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation
Prostaglandins Leukotrienes and Essential Fatty Acids 2020cited by 60position: middledoi
Identifying Immunophenotypes of Inflammation in Depression: Dismantling the Monolith
Biological Psychiatry 2020cited by 44position: firstdoi
Protein and gene markers of metabolic dysfunction and inflammation together associate with functional connectivity in reward and motor circuits in depression
Brain Behavior and Immunity 2020cited by 42position: lastdoi
Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls
Schizophrenia 2020cited by 27position: middledoi
Inflammation and decreased functional connectivity in a widely-distributed network in depression: Centralized effects in the ventral medial prefrontal cortex
Brain Behavior and Immunity 2019cited by 107position: lastdoi
Reward-related brain activity and behavior are associated with peripheral ghrelin levels in obesity
Psychoneuroendocrinology 2019cited by 34position: middledoi
What does plasma CRP tell us about peripheral and central inflammation in depression?
Molecular Psychiatry 2018cited by 439position: firstdoi
Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder
Psychoneuroendocrinology 2018cited by 272position: middledoi
Inflammation negatively correlates with amygdala-ventromedial prefrontal functional connectivity in association with anxiety in patients with depression: Preliminary results
Brain Behavior and Immunity 2018cited by 116position: lastdoi
Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia
Translational Psychiatry 2018cited by 109position: middledoi
Role of Inflammation in Depression and Treatment Implications
Handbook of experimental pharmacology 2018cited by 83position: firstdoi
Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression
Psychoneuroendocrinology 2018cited by 63position: lastdoi
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Current Neuropharmacology 2017cited by 420position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Andrew H. Miller · Albert Einstein College of Medicine36 papers (2012–2025)Ebrahim Haroon · Emory University26 papers (2013–2025)Bobbi J. Woolwine · Emory University20 papers (2012–2024)David R. Goldsmith · Emory University10 papers (2016–2022)Mandakh Bekhbat · Emory University8 papers (2018–2024)Zhihao Li · Shanghai University7 papers (2018–2022)Evanthia C. Wommack · Emory University7 papers (2015–2024)Mylin A. Torres · Emory Healthcare5 papers (2013–2017)Donna Mister · Emory University5 papers (2013–2017)Charles L. Raison · University of Wisconsin System5 papers (2012–2015)Neeti D. Mehta · Supernus Pharmaceuticals (United States)5 papers (2018–2022)Xiangchuan Chen · Woodruff Health Sciences Center5 papers (2014–2021)Canhua Xiao · Emory University4 papers (2015–2021)Maurizio Fava · Massachusetts General Hospital3 papers (2020–2023)David Mischoulon · Lemuel Shattuck Hospital3 papers (2020–2023)Trusharth Patel · Emory University3 papers (2018–2021)Wendy Baer · Emory Clinic3 papers (2018–2021)Ngoc‐Anh Le · Hanoi University of Science and Technology3 papers (2018–2020)Mark Hyman Rapaport · University of Utah3 papers (2020–2023)Thomas R. Ziegler · Emory University3 papers (2020–2023)